Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 162 citing Sesmilo: Effects of growth hormone administration on inflammatory and other cardiovascular.... (0.12 sec) 

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the …

- ahajournals.org
PM Ridker - Circulation, 2001 - Am Heart Assoc
Abstract—Inflammation plays a major role in atherothrombosis, and measurement
of inflammatory markers such as high-sensitivity C-reactive protein (HSCRP) may
provide a novel method for detecting individuals at high risk of plaque ...
Cited by 1012 - Related articles - BL Direct - All 7 versions

Regulation of adipocytokines and insulin resistance


M Fasshauer, R Paschke - Diabetologia, 2003 - Springer
It has long been known that obesity and insulin resis- tance are linked.
Recently, it has been shown that adi- pocytes secrete several proteins including
tumour ne- crosis factor-α, interleukin-6, resistin, and adiponec- tin. ...
Cited by 285 - Related articles - BL Direct - All 4 versions

The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm


P Dandona, A Aljada, P Mohanty - Diabetologia, 2002 - Springer
Hyperinsulinaemia has been known to be associated with an increase in coronary
heart disease and athe- rosclerosis for sometime [1ą4]. However, this associa-
tion has not been shown in all studies nor has it been shown to occur in ...
Cited by 183 - Related articles - BL Direct - All 3 versions

Estrogen regulation of growth hormone action

- endojournals.org
KC Leung, G Johannsson, GM Leong, KKY … - Endocrine reviews, 2004 - Endocrine Soc
GH plays a pivotal role in regulating body growth and development, which is
modulated by sex steroids. A close interplay between estrogen and GH leads to
attainment of genderspecific body composition during puberty. The ...
Cited by 116 - Related articles - BL Direct - All 5 versions

Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive …

- onlinejacc.org
W Vongpatanasin, M Tuncel, Z Wang, D Arbique … - Journal of the American College of Cardiology, 2003 - Elsevier
In 21 postmenopausal women, we conducted a randomized, crossover,
placebo-controlled study to compare the effects of transdermal versus oral ET on
CRP and inflammatory cytokines. We measured CRP, interleukin (IL)-1-beta, ...
Cited by 113 - Related articles - BL Direct - All 14 versions

Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and …

- endojournals.org
AR Cappola, QL Xue, L Ferrucci, JM Guralnik, … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc
The physiology of age-related functional decline is poorly understood, but may
involve hormones and inflammation. We hypothesized that older women with both
low IGF-I and high IL-6 levels are at high risk for disability and death. ...
Cited by 106 - Related articles - BL Direct - All 4 versions

Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical …

- endojournals.org
ME Molitch, DR Clemmons, S Malozowski, GR … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc
Participants: The chair of the Task Force was selected by the Clinical
Guidelines Subcommittee of The Endocrine Society (TES). The chair selected five
other endocrinologists and a medical writer, who were approved by the ...
Cited by 95 - Related articles - All 6 versions

Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient …

- endojournals.org
P Maison, S Griffin, M Nicoue-Beglah, N … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc
We conducted a systematic review of blinded, randomized, placebo-controlled
trials of GH treatment in adult patients with GH deficiency published up to
August 2003. Thirty-seven trials were identified. We combined the results ...
Cited by 90 - Related articles - BL Direct - All 4 versions

Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I …

- endojournals.org
G Sesmilo, WP Fairfield, L Katznelson, K … - Journal of Clinical Endocrinology & Metabolism, 2002 - Endocrine Soc
After baseline evaluation, patients with acromegaly were randomized to placebo
(n = 14), 10 mg (n = 12), 15 mg (n = 10), or 20 mg (n = 12) daily pegvisomant
for 12 wk. Subsequently, all patients received at least 10 mg pegvisomant ...
Cited by 72 - Related articles - BL Direct - All 5 versions

Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with …

- endojournals.org
C Franco, J Brandberg, L Lonn, B Andersson … - Journal of Clinical Endocrinology & Metabolism, 2005 - Endocrine Soc
GH treatment reduced visceral fat mass, increased thigh muscle area, and reduced
total and low-density lipoprotein cholesterol compared with placebo. Insulin
sensitivity was increased at 12 months compared with baseline values in the ...
Cited by 66 - Related articles - All 9 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google